Position in RPRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,965,943
+$1,104,101 QoQ
Shares Held
70,732
+18.6% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#220
of 641 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BTG Pactual Asset Management US LLC holds $6,060,072 across 7 Biotechnology names. RPRX ranks #1 (65.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
70,732 | $3,965,943 | |
| 2 | EXEL |
Exelixis, Inc.
|
6,873 | $373,959 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
591 | $368,512 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
1,123 | $354,969 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1,454 | $350,370 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
4,164 | $325,916 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
1,309 | $320,403 |
All Filings in RPRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,965,943 | 70,732 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,861,842 | 59,659 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,577,056 | 66,694 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,156,701 | 61,131 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $2,395,235 | 76,943 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,259,777 | 88,584 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,572,720 | 90,941 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||